Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1988 1
1989 2
1990 3
1991 3
1992 6
1993 6
1994 3
1995 5
1996 13
1997 11
1998 8
1999 8
2000 4
2001 5
2002 12
2003 9
2004 9
2005 17
2006 5
2007 11
2008 3
2009 8
2010 14
2011 17
2012 15
2013 19
2014 9
2015 12
2016 13
2017 9
2018 5
2019 5
2020 6
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

255 results
Results by year
Filters applied: . Clear all
Page 1
Gene Expression of Kallikreins in Breast Cancer Cell Lines.
Watrowski R, Castillo-Tong DC, Obermayr E, Zeillinger R. Watrowski R, et al. Among authors: zeillinger r. Anticancer Res. 2020 May;40(5):2487-2495. doi: 10.21873/anticanres.14219. Anticancer Res. 2020. PMID: 32366393
miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients.
Panoutsopoulou K, Avgeris M, Magkou P, Mavridis K, Dreyer T, Dorn J, Obermayr E, Reinthaller A, Michaelidou K, Mahner S, Vergote I, Loverix L, Braicu I, Sehouli J, Zeillinger R, Magdolen V, Scorilas A. Panoutsopoulou K, et al. Among authors: zeillinger r. Int J Cancer. 2020 Dec 15;147(12):3560-3573. doi: 10.1002/ijc.33182. Epub 2020 Aug 1. Int J Cancer. 2020. PMID: 32621752 Review.
Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer.
Kasimir-Bauer S, Roder J, Obermayr E, Mahner S, Vergote I, Loverix L, Braicu E, Sehouli J, Concin N, Kimmig R, Net L, Roder H, Zeillinger R, Aust S, On Behalf Of The Ovcad Ovarian Cancer Diagnosis Initiative. Kasimir-Bauer S, et al. Among authors: zeillinger r. Cancers (Basel). 2020 Sep 4;12(9):2519. doi: 10.3390/cancers12092519. Cancers (Basel). 2020. PMID: 32899818 Free PMC article.
Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer.
Meshcheryakova A, Svoboda M, Jaritz M, Mungenast F, Salzmann M, Pils D, Cacsire Castillo-Tong D, Hager G, Wolf A, Braicu EI, Sehouli J, Lambrechts S, Vergote I, Mahner S, Birner P, Zimmermann P, Brindley DN, Heinze G, Zeillinger R, Mechtcheriakova D. Meshcheryakova A, et al. Among authors: zeillinger r. Comput Struct Biotechnol J. 2019 Apr 10;17:537-560. doi: 10.1016/j.csbj.2019.04.004. eCollection 2019. Comput Struct Biotechnol J. 2019. PMID: 31049165 Free PMC article.
Patient satisfaction after breast cancer surgery : A prospective clinical trial.
Leser C, Tan YY, Singer C, Zeillinger R, Fitzal F, Lehrner J, König D, Deutschmann C, Gschwantler-Kaulich D. Leser C, et al. Among authors: zeillinger r. Wien Klin Wochenschr. 2021 Jan;133(1-2):6-13. doi: 10.1007/s00508-020-01730-w. Epub 2020 Sep 3. Wien Klin Wochenschr. 2021. PMID: 32880714 Free PMC article. Clinical Trial.
miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study.
Panoutsopoulou K, Avgeris M, Mavridis K, Dreyer T, Dorn J, Obermayr E, Reinthaller A, Michaelidou K, Mahner S, Vergote I, Vanderstichele A, Braicu I, Sehouli J, Zeillinger R, Magdolen V, Scorilas A. Panoutsopoulou K, et al. Among authors: zeillinger r. Carcinogenesis. 2020 Jun 17;41(4):442-451. doi: 10.1093/carcin/bgz163. Carcinogenesis. 2020. PMID: 31586203
Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan.
Salk JJ, Loubet-Senear K, Maritschnegg E, Valentine CC, Williams LN, Higgins JE, Horvat R, Vanderstichele A, Nachmanson D, Baker KT, Emond MJ, Loter E, Tretiakova M, Soussi T, Loeb LA, Zeillinger R, Speiser P, Risques RA. Salk JJ, et al. Among authors: zeillinger r. Cell Rep. 2019 Jul 2;28(1):132-144.e3. doi: 10.1016/j.celrep.2019.05.109. Cell Rep. 2019. PMID: 31269435 Free PMC article.
255 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page